Medifast: Q4 Earnings Insights

Medifast MED reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Medifast beat estimated earnings by 9.81%, reporting an EPS of $2.91 versus an estimate of $2.65.

Revenue was up $112.92 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.48 which was followed by a 2.92% increase in the share price the next day.

Here's a look at Medifast's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 3.08 3.31 2.73 2.38
EPS Actual 3.56 3.96 3.46 2.36
Revenue Estimate 403.76M 358.45M 278.89M 244.49M
Revenue Actual 413.39M 394.19M 340.67M 264.91M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

Medifast management provided guidance for their next quarter, expecting earnings between $14.5 and $16.0 per share for the next quarter.

This represents a 424.05% in quarter-over-quarter growth for Medifast, a bullish signal to many investors.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

MED Logo
MEDMedifast Inc
$14.075.24%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
14.08
Growth
9.67
Quality
-
Value
94.17
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...